Overview

Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

Evaluate the efficacy and safety of Doxorubicin Hydrochloride Liposome Injection Plus Cyclophosphamide Compared to Pirarubicin Plus Cyclophosphamide as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients

Phase:

Phase 4

Details

Lead Sponsor:

Hebei Medical University Fourth Hospital

Treatments:

Cyclophosphamide
Doxorubicin
Liposomal doxorubicin
Pirarubicin